Tecan Group (OTCMKTS:TCHBF)‘s stock had its “buy” rating reissued by equities research analysts at Berenberg Bank in a research note issued to investors on Wednesday, AnalystRatings.com reports. They currently have a $275.00 target price on the stock. Berenberg Bank’s target price suggests a potential upside of 7.36% from the company’s current price.
Shares of TCHBF opened at $256.15 on Wednesday.
About Tecan Group
Tecan Group Ltd. provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company develops, produces, markets, and supports automated workflow solutions, including laboratory instruments, software packages, application knowhow, services, consumables, and spare parts for molecular diagnostics, tissue diagnostics, immunodiagnostics, and mass spectrometry diagnostics; and develops and manufactures original equipment manufacturer instruments and components.
Further Reading: Initial Coin Offering (ICO)
Receive News & Ratings for Tecan Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Tecan Group and related companies with MarketBeat.com’s FREE daily email newsletter.